• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胆钙化醇补充剂不能预防肾移植的结构和功能恶化:一项回顾性研究。

Cholecalciferol supplementation does not protect against renal allograft structural and functional deterioration: a retrospective study.

机构信息

Service de Néphrologie, Hôpital Tenon-Assistance Publique-Hôpitaux de Paris et Université Paris VI, Paris, France.

出版信息

Transplantation. 2011 Jan 27;91(2):207-12. doi: 10.1097/TP.0b013e318200ba37.

DOI:10.1097/TP.0b013e318200ba37
PMID:21131899
Abstract

BACKGROUND

Apart from their important role in mediating calcium homeostasis, vitamin D derivatives regulate numerous vitamin D receptor-mediated renoprotective cellular functions including cell differentiation, negative regulation of inflammation, and fibrosis. Renal models of chronic kidney injury and clinical observational studies have suggested that vitamin D analogues may protect against the epithelial-to-mesenchymal transition (EMT), interstitial inflammation, and fibrosis.

METHODS

The aim of this retrospective study is to test whether oral supplementation with cholecalciferol (vitamin D3) between 3 and 12 months posttransplantation confers a structural and functional nephroprotection in a population of 64 renal transplant patients, using historical controls. We analyzed glomerular filtration rates using iohexol clearance, urinary procollagen III aminoterminal propeptide excretion, and epithelial phenotypic changes as markers of the EMT and Banff scores at 3 and 12 months after transplantation in 64 renal transplant recipients with or without cholecalciferol supplementation between months 3 and 12.

RESULTS

Cholecalciferol supplementation in stable renal transplant recipients did not prevent EMT, interstitial fibrosis, tubular atrophy, or renal function deterioration.

CONCLUSION

Our results challenge the experimental data, suggesting that vitamin D-analog supplementation confers nephroprotection. These findings should be confirmed by randomized prospective studies.

摘要

背景

除了在调节钙稳态方面发挥重要作用外,维生素 D 衍生物还调节多种维生素 D 受体介导的肾保护细胞功能,包括细胞分化、炎症负调节和纤维化。慢性肾损伤的肾脏模型和临床观察性研究表明,维生素 D 类似物可能对上皮-间充质转化(EMT)、间质炎症和纤维化具有保护作用。

方法

本回顾性研究的目的是在 64 名肾移植患者中,使用历史对照,检测在移植后 3 至 12 个月期间口服补充胆钙化醇(维生素 D3)是否能提供结构和功能的肾脏保护作用。我们使用 iohexol 清除率分析肾小球滤过率,用尿原胶原 III 氨基末端前肽排泄和上皮表型变化作为 EMT 的标志物,在移植后 3 和 12 个月用 Banff 评分分析,观察有无胆钙化醇补充的 64 例肾移植患者。

结果

在稳定的肾移植受者中补充胆钙化醇不能预防 EMT、间质纤维化、肾小管萎缩或肾功能恶化。

结论

我们的结果对实验数据提出了挑战,表明维生素 D 类似物补充具有肾脏保护作用。这些发现需要通过随机前瞻性研究来证实。

相似文献

1
Cholecalciferol supplementation does not protect against renal allograft structural and functional deterioration: a retrospective study.胆钙化醇补充剂不能预防肾移植的结构和功能恶化:一项回顾性研究。
Transplantation. 2011 Jan 27;91(2):207-12. doi: 10.1097/TP.0b013e318200ba37.
2
Urinary amino-terminal propeptide of type III procollagen (PIIINP) as a marker of interstitial fibrosis in renal transplant recipients.尿Ⅲ型前胶原氨基端肽(PIIINP)作为肾移植受者间质纤维化的标志物。
Transplantation. 2003 Jun 27;75(12):2113-9. doi: 10.1097/01.TP.0000066809.60389.48.
3
[Causes of late renal transplant dysfunction].[晚期肾移植功能障碍的原因]
Orv Hetil. 2002 Dec 22;143(51):2811-9.
4
Determinants of long-term graft outcome in transplant glomerulopathy.移植肾肾小球病长期移植物预后的决定因素。
Transplantation. 2010 Oct 15;90(7):757-64. doi: 10.1097/TP.0b013e3181efcffd.
5
Impact of parathyroidectomy on renal graft function, blood pressure and serum lipids in kidney transplant recipients: a single centre study.甲状旁腺切除术对肾移植受者肾移植功能、血压和血脂的影响:一项单中心研究
Nephrol Dial Transplant. 2005 Aug;20(8):1714-20. doi: 10.1093/ndt/gfh892. Epub 2005 May 26.
6
Pathogenesis of tubulointerstitial fibrosis in chronic allograft dysfunction.慢性移植肾失功中肾小管间质性纤维化的发病机制。
Clin Transplant. 2009 Dec;23 Suppl 21:26-32. doi: 10.1111/j.1399-0012.2009.01106.x.
7
Induction of chronic renal allograft injury by injection of a monoclonal antibody against a donor MHC Ib molecule in a nude rat model.在裸鼠模型中,通过注射针对供体MHC Ib分子的单克隆抗体诱导慢性同种异体肾移植损伤。
Transpl Immunol. 2008 Jul;19(3-4):187-91. doi: 10.1016/j.trim.2008.05.006. Epub 2008 Jun 13.
8
Clinical implications of proteinuria in renal transplant recipients switching to rapamycin for chronic allograft dysfunction.肾移植受者因慢性移植肾失功改用雷帕霉素时蛋白尿的临床意义
Transplant Proc. 2009 Jul-Aug;41(6):2348-50. doi: 10.1016/j.transproceed.2009.06.163.
9
Intragraft tubular vimentin and CD44 expression correlate with long-term renal allograft function and interstitial fibrosis and tubular atrophy.移植肾内管型波形蛋白和 CD44 的表达与长期肾移植功能和间质纤维化及肾小管萎缩相关。
Transplantation. 2010 Sep 15;90(5):502-9. doi: 10.1097/TP.0b013e3181e86b42.
10
The contribution of reduced functioning mass to chronic kidney allograft dysfunction in rats.功能质量降低对大鼠慢性肾移植功能障碍的影响。
Transplantation. 1994 Dec 27;58(12):1317-22.

引用本文的文献

1
Vitamin D and the Kidney: Two Players, One Console.维生素 D 与肾脏:二者犹如双剑合璧
Int J Mol Sci. 2022 Aug 15;23(16):9135. doi: 10.3390/ijms23169135.
2
Hypovitaminosis D Is Prevalent in Patients With Renal AL Amyloidosis and Associated With Renal Outcome.维生素 D 缺乏症在肾淀粉样变性患者中普遍存在,并与肾脏预后相关。
Front Endocrinol (Lausanne). 2022 Jun 21;13:891712. doi: 10.3389/fendo.2022.891712. eCollection 2022.
3
Vitamin D Receptor Activity, Vitamin D Status, and Development of De-novo Donor-specific Antibody after Renal Transplantation.
维生素D受体活性、维生素D状态与肾移植后新发供者特异性抗体的产生
Indian J Nephrol. 2020 Mar-Apr;30(2):72-76. doi: 10.4103/ijn.IJN_353_18. Epub 2020 Feb 7.
4
Impact of seasonality on the dynamics of native Vitamin D repletion in long-term renal transplant patients.季节性对长期肾移植患者体内天然维生素D补充动态的影响。
Clin Kidney J. 2017 Jun;10(3):411-418. doi: 10.1093/ckj/sfw136. Epub 2017 Jan 7.
5
Nutritional Vitamin D in Renal Transplant Patients: Speculations and Reality.肾移植患者的营养性维生素D:推测与现实
Nutrients. 2017 May 27;9(6):550. doi: 10.3390/nu9060550.
6
Current evidence on vitamin D deficiency and kidney transplant: What's new?维生素D缺乏与肾移植的当前证据:有哪些新进展?
Rev Endocr Metab Disord. 2017 Sep;18(3):323-334. doi: 10.1007/s11154-017-9418-z.
7
Phosphocalcic Markers and Calcification Propensity for Assessment of Interstitial Fibrosis and Vascular Lesions in Kidney Allograft Recipients.用于评估肾移植受者间质纤维化和血管病变的磷酸钙标志物及钙化倾向
PLoS One. 2016 Dec 30;11(12):e0167929. doi: 10.1371/journal.pone.0167929. eCollection 2016.
8
Kidney Fibrosis: Origins and Interventions.肾纤维化:起源与干预措施
Transplantation. 2017 Apr;101(4):713-726. doi: 10.1097/TP.0000000000001608.
9
Vitamin D in patients with chronic kidney disease: a position statement of the Working Group "Trace Elements and Mineral Metabolism" of the Italian Society of Nephrology.慢性肾病患者的维生素D:意大利肾脏病学会“微量元素与矿物质代谢”工作组的立场声明
J Nephrol. 2016 Jun;29(3):305-328. doi: 10.1007/s40620-016-0305-6. Epub 2016 Apr 9.
10
Vitamin D deficiency is associated with increased risk of bacterial infections after kidney transplantation.维生素D缺乏与肾移植后细菌感染风险增加有关。
Korean J Intern Med. 2017 May;32(3):505-513. doi: 10.3904/kjim.2015.214. Epub 2016 Mar 25.